Inovio Pharmaceuticals In...

2.08
0.17 (8.90%)
At close: Jan 17, 2025, 3:59 PM
2.08
-0.24%
After-hours Jan 17, 2025, 07:37 PM EST

Inovio Pharmaceuticals Statistics

Share Statistics

Inovio Pharmaceuticals has 36.10M shares outstanding. The number of shares has increased by 54.47% in one year.

Shares Outstanding 36.10M
Shares Change (YoY) n/a
Shares Change (QoQ) 39.04%
Owned by Institutions (%) n/a
Shares Floating 35.80M
Failed to Deliver (FTD) Shares 19.34K
FTD / Avg. Volume 2.15%

Short Selling Information

The latest short interest is 3.50M, so 9.71% of the outstanding shares have been sold short.

Short Interest 3.50M
Short % of Shares Out 9.71%
Short % of Float 9.82%
Short Ratio (days to cover) 11.22

Valuation Ratios

The PE ratio is -1 and the forward PE ratio is -1.39.

PE Ratio -1
Forward PE -1.39
PS Ratio 163.1
Forward PS 2.8
PB Ratio 1.16
P/FCF Ratio -1.09
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Inovio Pharmaceuticals Inc. has an Enterprise Value (EV) of 151.60M.

EV / Earnings -1.12
EV / Sales 182.21
EV / EBITDA -1.16
EV / EBIT -1.05
EV / FCF -1.22

Financial Position

The company has a current ratio of 3.6, with a Debt / Equity ratio of 0.26.

Current Ratio 3.6
Quick Ratio 3.6
Debt / Equity 0.26
Total Debt / Capitalization 20.47
Cash Flow / Debt -4.12
Interest Coverage -117.71

Financial Efficiency

Return on equity (ROE) is -1.15% and return on capital (ROIC) is -97.55%.

Return on Equity (ROE) -1.15%
Return on Assets (ROA) -0.78%
Return on Capital (ROIC) -97.55%
Revenue Per Employee 6.55K
Profits Per Employee -1.06M
Employee Count 127
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -74.29% in the last 52 weeks. The beta is 0.83, so Inovio Pharmaceuticals 's price volatility has been higher than the market average.

Beta 0.83
52-Week Price Change -74.29%
50-Day Moving Average 3.3
200-Day Moving Average 7.35
Relative Strength Index (RSI) 39.63
Average Volume (20 Days) 898.28K

Income Statement

In the last 12 months, Inovio Pharmaceuticals had revenue of 832.01K and earned -135.12M in profits. Earnings per share was -6.09.

Revenue 832.01K
Gross Profit -2.67M
Operating Income -143.94M
Net Income -135.12M
EBITDA -130.39M
EBIT -143.94M
Earnings Per Share (EPS) -6.09
Full Income Statement

Balance Sheet

The company has 14.31M in cash and 30.21M in debt, giving a net cash position of -15.90M.

Cash & Cash Equivalents 14.31M
Total Debt 30.21M
Net Cash -15.90M
Retained Earnings -1.62B
Total Assets 107.06M
Working Capital 67.79B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -124.37M and capital expenditures -320.90K, giving a free cash flow of -124.69M.

Operating Cash Flow -124.37M
Capital Expenditures -320.90K
Free Cash Flow -124.69M
FCF Per Share -5.62
Full Cash Flow Statement

Margins

Gross margin is -321.09%, with operating and profit margins of -17.30K% and -16.24K%.

Gross Margin -321.09%
Operating Margin -17.30K%
Pretax Margin -16.24K%
Profit Margin -16.24K%
EBITDA Margin -15.67K%
EBIT Margin -17.30K%
FCF Margin -14.99K%

Dividends & Yields

INO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -292.79%
FCF Yield -165.66%
Dividend Details

Analyst Forecast

The average price target for INO is $15, which is 621.2% higher than the current price. The consensus rating is "Buy".

Price Target $15
Price Target Difference 621.2%
Analyst Consensus Buy
Analyst Count 5
Stock Forecasts

Stock Splits

The last stock split was on Jan 25, 2024. It was a backward split with a ratio of 1:12.

Last Split Date Jan 25, 2024
Split Type backward
Split Ratio 1:12

Scores

Altman Z-Score 735.18
Piotroski F-Score 1